Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | CHCl3 |
| Molecular Weight | 119.378 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC(Cl)Cl
InChI
InChIKey=HEDRZPFGACZZDS-UHFFFAOYSA-N
InChI=1S/CHCl3/c2-1(3)4/h1H
| Molecular Formula | CHCl3 |
| Molecular Weight | 119.378 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chloroform is a colorless, sweet-smelling, dense liquid and widely used industrial and laboratory solvent. The total global flux of chloroform through the environment is approximately 660 000 tonnes per year, and about 90% of emissions are natural in origin. Many kinds of seaweed produce chloroform, and fungi are believed to produce chloroform in soil. Chloroform is used as an industrial solvent and as an intermediate in the manufacture of polymeric materials. The major use of chloroformtoday is in the production of the refrigerant R-22, commonly used in the air conditioning business. Inhaled chloroform anesthesia was introduced in 1847 and Chloroform subsequently became the most widely used volatile anaesthetic, and was used in horses before the end of the 19th century. Pure chloroform is known to be decomposed by the air with the formation of hydrochloric acid, phosgene and carbon dioxide. Phosgene is also generated metabolically from chloroform, and liver and kidney damage can ensue from its production.
Originator
Approval Year
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
293 μg × min/mL |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: MALE food status: UNKNOWN |
|
176 μg × min/mL |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: FEMALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
96 min |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: MALE food status: UNKNOWN |
|
86 min |
500 mg single, oral dose: 500 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROFORM blood | Homo sapiens population: UNKNOWN age: UNKNOWN sex: FEMALE food status: UNKNOWN |
Doses
| Dose | Population | Adverse events |
|---|---|---|
30 mL single, oral Overdose |
healthy, 30 |
Disc. AE: Loss of consciousness, Hypotension... AEs leading to discontinuation/dose reduction: Loss of consciousness Sources: Hypotension Respiratory depression (severe) Abdominal pain (severe) Vomiting Diarrhea Enterocolitis (severe) Erosive oesophagitis (severe) Gastritis erosive (severe) Ulceration (severe) Contact dermatitis ALT increased AST increased |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: |
unknown |
Disc. AE: Respiratory failure, Cardiac arrhythmias... AEs leading to discontinuation/dose reduction: Respiratory failure (grade 5) Sources: Cardiac arrhythmias (grade 5) Cardiac failure (grade 5) |
1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
Disc. AE: Dizziness, Intracranial pressure increase... AEs leading to discontinuation/dose reduction: Dizziness Sources: Intracranial pressure increase Nausea Headache |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| ALT increased | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| AST increased | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| Contact dermatitis | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| Diarrhea | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| Hypotension | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| Loss of consciousness | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| Vomiting | Disc. AE | 30 mL single, oral Overdose |
healthy, 30 |
| Abdominal pain | severe Disc. AE |
30 mL single, oral Overdose |
healthy, 30 |
| Enterocolitis | severe Disc. AE |
30 mL single, oral Overdose |
healthy, 30 |
| Erosive oesophagitis | severe Disc. AE |
30 mL single, oral Overdose |
healthy, 30 |
| Gastritis erosive | severe Disc. AE |
30 mL single, oral Overdose |
healthy, 30 |
| Respiratory depression | severe Disc. AE |
30 mL single, oral Overdose |
healthy, 30 |
| Ulceration | severe Disc. AE |
30 mL single, oral Overdose |
healthy, 30 |
| Cardiac arrhythmias | grade 5 Disc. AE |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: |
unknown |
| Cardiac failure | grade 5 Disc. AE |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: |
unknown |
| Respiratory failure | grade 5 Disc. AE |
73 g/m3 single, respiratory Recommended Dose: 73 g/m3 Route: respiratory Route: single Dose: 73 g/m3 Sources: |
unknown |
| Dizziness | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
| Headache | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
| Intracranial pressure increase | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
| Nausea | Disc. AE | 1030 ppm single, respiratory Studied dose Dose: 1030 ppm Route: respiratory Route: single Dose: 1030 ppm Sources: |
healthy |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. | 2001-07-06 |
|
| Evaluation of diimine ligand exchange on Cu(I). | 2001-05-21 |
|
| Sequence specificity of hydrogen-bonded molecular duplexes. | 2001-05-18 |
|
| Rigorous interpretation of electronic density functions of axial and equatorial conformers of dimethylphosphinoylcyclohexane, 2-(dimethylphosphinoyl)-1,3,5-trithiane, and 2-(dimethylphosphinoyl)-1,3-dithiane-1,1,3,3-tetraoxide. | 2001-05-04 |
|
| Lipase catalyzed synthesis of organic acid esters of lactic acid in non-aqueous media. | 2001-05-04 |
|
| Fabrication of poly(phosphoester) nerve guides by immersion precipitation and the control of porosity. | 2001-05 |
|
| A controlled field experiment on groundwater contamination by a multicomponent DNAPL: creation of the emplaced-source and overview of dissolved plume development. | 2001-05 |
|
| Cytotoxic activity of Typhonium flagelliforme (Araceae). | 2001-05 |
|
| Improved method for the recovery of hepatitis A virus from oysters. | 2001-05 |
|
| Long-term effects on male reproduction of early exposure to common chemical contaminants in drinking water. | 2001-05 |
|
| An improved method for isolation of unconjugated bilirubin from rat and dog bile. | 2001-05 |
|
| Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. | 2001-05 |
|
| Screening of various Swertia species extracts in primary monolayer cultures of rat hepatocytes against carbon tetrachloride- and paracetamol-induced toxicity. | 2001-05 |
|
| Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel. | 2001-05 |
|
| Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. | 2001-05 |
|
| Measurement of potency and lipids in monensin fermentation broth by near-infrared spectroscopy. | 2001-05 |
|
| Anesthetic-like interactions of nitric oxide with albumin and hemeproteins. A mechanism for control of protein function. | 2001-04-27 |
|
| First isolation and characterization of eight regioisomers for [60]fullerene-benzene bisadducts. | 2001-04-19 |
|
| Synthesis and self-aggregation of cyclic alkynes containing helicene. | 2001-04-19 |
|
| [New studies on the history of anesthesiology--(7). What anesthetics were given to soldiers of the fifth regiment rescued from death march on Mount Hakkoda?]. | 2001-04 |
|
| Labdane and pimarane diterpenes from Croton joufra. | 2001-04 |
|
| Two stereoisomeric pentacyclic oxindole alkaloids from Uncaria tomentosa: uncarine C and uncarine E. | 2001-04 |
|
| Determination of ochratoxin A in red wine and vinegar by immunoaffinity high-pressure liquid chromatography. | 2001-04 |
|
| Benzene-extracted components are important for the major activity of diesel exhaust particles: effect on interleukin-8 gene expression in human bronchial epithelial cells. | 2001-04 |
|
| The Bacillus subtilis yabQ gene is essential for formation of the spore cortex. | 2001-04 |
|
| Antiimplantation and pregnancy interruption efficacy of Rivea hypocrateriformis in the rat. | 2001-03-03 |
|
| Photochemistry of the pi-extended 9,10-bis(1,3-dithiol-2-ylidene)-9,10-dihydroanthracene system: generation and characterisation of the radical cation, dication, and derived products. | 2001-03-02 |
|
| Extraction of iridium (IV) from hydrochloric acid media with crown ether in chloroform, and its determination by ICP-AES. | 2001-03 |
|
| A new spectrophotometric method for the determination of total and ferric iron in rain water at the ppb level. | 2001-03 |
|
| Efficiency of rice bran for removal of organochlorine compounds and benzene from industrial wastewater. | 2001-03 |
|
| The role of nitric oxide on cigarette smoke-induced programmed cell death in the gastric mucosa. | 2001-03 |
|
| Biosynthesis of PHB tercopolymer by Bacillus cereus UW85. | 2001-03 |
|
| Molecular mechanisms of anesthesia. | 2001-03 |
|
| Mast cell stabilising activity of Bacopa monnieri. | 2001-03 |
|
| Isolation of genomic DNA from feathers. | 2001-03 |
|
| Transient absorption from the 1Bu+ state of all-trans-beta-carotene newly identified in the near-infrared region. | 2001-03 |
|
| Fluorometric method for the simultaneous quantitation of differently-sized nanoparticles in rodent tissue. | 2001-02-19 |
|
| Understanding the role of internal lysine residues of serum albumins in conformational stability and bilirubin binding. | 2001-02-09 |
|
| Carbon tetrachloride dechlorination by the bacterial transition metal chelator pyridine-2,6-bis(thiocarboxylic acid). | 2001-02-01 |
|
| Reductive dechlorination of cis-1,2-dichloroethene and vinyl chloride by "Dehalococcoides ethenogenes". | 2001-02-01 |
|
| Long-term follow-up on keratocysts treated according to a defined protocol. | 2001-02 |
|
| Influence of N-terminal residue stereochemistry on the prolyl amide geometry and the conformation of 5-tert-butylproline type VI beta-turn mimics. | 2001-02 |
|
| Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. | 2001-01 |
|
| Direct measurements of hemoglobin interactions with liposomes using EPR spectroscopy. | 2001-01 |
|
| 7Li-NMR and FTIR studies of lithium, potassium, rubidium, and cesium complexes with ionophore lasalocid in solution. | 2001 |
|
| Purification and characterization of catalase from chard (Beta vulgaris var. cicla). | 2001 |
|
| Inhibition of spontaneous induction of lambdoid prophages in Escherichia coli cultures: simple procedures with possible biotechnological applications. | 2001 |
|
| Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. | 2001 |
|
| Incidence of seed-borne fungi and aflatoxins in Sudanese lentil seeds. | 2001 |
|
| Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:35 GMT 2025
by
admin
on
Mon Mar 31 17:48:35 GMT 2025
|
| Record UNII |
7V31YC746X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
20701
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
||
|
WHO-VATC |
QN01AB02
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
||
|
NCI_THESAURUS |
C45386
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
||
|
IARC | Chloroform | ||
|
WHO-ATC |
N01AB02
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
||
|
CFR |
21 CFR 310.502
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
||
|
CFR |
21 CFR 216.24
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
||
|
CFR |
21 CFR 700.18
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
35255
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
67-66-3
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
200-663-8
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
4363
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
1601383
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
56
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
m3412
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL44618
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
DTXSID1020306
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
SUB13331MIG
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
77361
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
SUB13333MIG
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
ALTERNATIVE | |||
|
C29815
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
D002725
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
1362698
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | RxNorm | ||
|
6212
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
7V31YC746X
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
100000080074
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
chloroform
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
7V31YC746X
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
CHLOROFORM
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
DB11387
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY | |||
|
SUB29129
Created by
admin on Mon Mar 31 17:48:35 GMT 2025 , Edited by admin on Mon Mar 31 17:48:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE TOXIC -> PARENT |
Renal tubular and hepatic necrosis in man.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|